Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nogues

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Breast Cancer Research and Treatment|April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predispositionE Rouleau, B Jesson, A Briaux, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapyF Poumeaud, T Valentin, N Fares, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Breast Cancer Research and Treatment|April 6, 2012
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predispositionE Rouleau, B Jesson, A Briaux, et al.
Bulletin Du Cancer|July 19, 2001
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management]T Frebourg, A Abel, C Bonaiti-Pellie, et al.
Journal of Medical Genetics|September 5, 2006
The contribution of germline rearrangements to the spectrum of BRCA2 mutationsF Casilli, I Tournier, O M Sinilnikova, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2025
Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapyF Poumeaud, T Valentin, N Fares, et al.
British Journal of Cancer|August 27, 2009
The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersO M Sinilnikova, A C Antoniou, J Simard, et al.
Pageof 6